Cargando…
Brain natriuretic peptide measurements using standard biochemical equipment: Comparisons with conventional immunoassays
BACKGROUND: Brain natriuretic peptide (BNP) is an essential cardiac biomarker for diagnosing heart failure and for prognoses in patients with various cardiac diseases. However, measurement requires immunological assays that are not available in every hospital. Recently, a novel BNP kit (Nanopia BNP-...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128988/ https://www.ncbi.nlm.nih.gov/pubmed/35609039 http://dx.doi.org/10.1371/journal.pone.0268895 |
_version_ | 1784712664326340608 |
---|---|
author | Higa, Yukie Nabeshima, Yosuke Kitano, Tetsuji Kataoka, Masaharu Nakazono, Akemi Takeuchi, Masaaki |
author_facet | Higa, Yukie Nabeshima, Yosuke Kitano, Tetsuji Kataoka, Masaharu Nakazono, Akemi Takeuchi, Masaaki |
author_sort | Higa, Yukie |
collection | PubMed |
description | BACKGROUND: Brain natriuretic peptide (BNP) is an essential cardiac biomarker for diagnosing heart failure and for prognoses in patients with various cardiac diseases. However, measurement requires immunological assays that are not available in every hospital. Recently, a novel BNP kit (Nanopia BNP-A, Sekisui Inc.; BNPn) that uses general-purpose, automated, biochemical analyzers has become commercially available. We assessed how its accuracy and utility compare with those of conventional immunological tests. METHODS AND RESULTS: We retrospectively collected 1491 conventional BNP measurements (BNPc), which had been clinically indicated for BNP testing and for which residual samples were still stored in the laboratory. We measured BNP using the novel kit and determined the correlation of BNP levels between the two methods. We also assessed the predictive value of both BNP measurements for major cardiac events (MACEs). The analytical performance of both measuring methods was similar. Log-transformed BNP measured by both methods showed strong correlation (r = 0.92); however, log-transformed BNPn was significantly higher than log-transformed BNPc (p<0.001). BNPc of 200 ng/L was used to stratify patients into two groups. According to the regression formula between the two methods, we determined a cut-off value of BNPn as 250 ng/L. During a median of 15 months of follow-up, 43 MACEs developed. Both BNPc and BNPn were associated with MACEs. Kaplan-Meier survival analysis indicated that both BNPc and BNPn cut-off values stratified the high-risk group for prognostication. The diagnostic and prognostic utilities were proven even if the lower cut-off values (BNPc = 100 ng/L, BNPn = 130 ng/L) were employed. CONCLUSIONS: A new BNP measurement using biochemical equipment provides prognostic value similar to that of conventional BNP analysis; thus, it should prove useful in hospitals in which conventional immunological examinations are not available. |
format | Online Article Text |
id | pubmed-9128988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-91289882022-05-25 Brain natriuretic peptide measurements using standard biochemical equipment: Comparisons with conventional immunoassays Higa, Yukie Nabeshima, Yosuke Kitano, Tetsuji Kataoka, Masaharu Nakazono, Akemi Takeuchi, Masaaki PLoS One Research Article BACKGROUND: Brain natriuretic peptide (BNP) is an essential cardiac biomarker for diagnosing heart failure and for prognoses in patients with various cardiac diseases. However, measurement requires immunological assays that are not available in every hospital. Recently, a novel BNP kit (Nanopia BNP-A, Sekisui Inc.; BNPn) that uses general-purpose, automated, biochemical analyzers has become commercially available. We assessed how its accuracy and utility compare with those of conventional immunological tests. METHODS AND RESULTS: We retrospectively collected 1491 conventional BNP measurements (BNPc), which had been clinically indicated for BNP testing and for which residual samples were still stored in the laboratory. We measured BNP using the novel kit and determined the correlation of BNP levels between the two methods. We also assessed the predictive value of both BNP measurements for major cardiac events (MACEs). The analytical performance of both measuring methods was similar. Log-transformed BNP measured by both methods showed strong correlation (r = 0.92); however, log-transformed BNPn was significantly higher than log-transformed BNPc (p<0.001). BNPc of 200 ng/L was used to stratify patients into two groups. According to the regression formula between the two methods, we determined a cut-off value of BNPn as 250 ng/L. During a median of 15 months of follow-up, 43 MACEs developed. Both BNPc and BNPn were associated with MACEs. Kaplan-Meier survival analysis indicated that both BNPc and BNPn cut-off values stratified the high-risk group for prognostication. The diagnostic and prognostic utilities were proven even if the lower cut-off values (BNPc = 100 ng/L, BNPn = 130 ng/L) were employed. CONCLUSIONS: A new BNP measurement using biochemical equipment provides prognostic value similar to that of conventional BNP analysis; thus, it should prove useful in hospitals in which conventional immunological examinations are not available. Public Library of Science 2022-05-24 /pmc/articles/PMC9128988/ /pubmed/35609039 http://dx.doi.org/10.1371/journal.pone.0268895 Text en © 2022 Higa et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Higa, Yukie Nabeshima, Yosuke Kitano, Tetsuji Kataoka, Masaharu Nakazono, Akemi Takeuchi, Masaaki Brain natriuretic peptide measurements using standard biochemical equipment: Comparisons with conventional immunoassays |
title | Brain natriuretic peptide measurements using standard biochemical equipment: Comparisons with conventional immunoassays |
title_full | Brain natriuretic peptide measurements using standard biochemical equipment: Comparisons with conventional immunoassays |
title_fullStr | Brain natriuretic peptide measurements using standard biochemical equipment: Comparisons with conventional immunoassays |
title_full_unstemmed | Brain natriuretic peptide measurements using standard biochemical equipment: Comparisons with conventional immunoassays |
title_short | Brain natriuretic peptide measurements using standard biochemical equipment: Comparisons with conventional immunoassays |
title_sort | brain natriuretic peptide measurements using standard biochemical equipment: comparisons with conventional immunoassays |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128988/ https://www.ncbi.nlm.nih.gov/pubmed/35609039 http://dx.doi.org/10.1371/journal.pone.0268895 |
work_keys_str_mv | AT higayukie brainnatriureticpeptidemeasurementsusingstandardbiochemicalequipmentcomparisonswithconventionalimmunoassays AT nabeshimayosuke brainnatriureticpeptidemeasurementsusingstandardbiochemicalequipmentcomparisonswithconventionalimmunoassays AT kitanotetsuji brainnatriureticpeptidemeasurementsusingstandardbiochemicalequipmentcomparisonswithconventionalimmunoassays AT kataokamasaharu brainnatriureticpeptidemeasurementsusingstandardbiochemicalequipmentcomparisonswithconventionalimmunoassays AT nakazonoakemi brainnatriureticpeptidemeasurementsusingstandardbiochemicalequipmentcomparisonswithconventionalimmunoassays AT takeuchimasaaki brainnatriureticpeptidemeasurementsusingstandardbiochemicalequipmentcomparisonswithconventionalimmunoassays |